ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed May 2, 2016
Insider Transaction Report
Form 4
Haluska Frank
VP, Clinical R&D, CMO
Transactions
- Exercise/Conversion
Common Stock
2016-04-29+17,334→ 164,345 total - Tax Payment
Common Stock
2016-04-29$7.18/sh−5,634$40,452→ 158,711 total - Exercise/Conversion
Restricted Stock Units
2016-04-29−17,334→ 0 totalExercise: $0.00→ Common Stock (17,334 underlying)
Footnotes (4)
- [F1]shares were acquired upon the vesting of an RSU granted April 29, 2015
- [F2]Represents shares withheld to satisfy withholding tax requirements
- [F3]Restricted stock units vest as to 33-1/3% of the award on each of April 29, 2016, April 29, 2017 and April 29, 2018.
- [F4]N/A